2012 Program
+ EXPAND all sections
To expand/collapse individual sections, click the section title or grey arrow.
Sunday, 26 February
15:00-19:30 Early Check-In & Registration
- Foyer, 1
st Floor
Visit the registration desk to check-in on Sunday, which allows you to jump-start your networking opportunities at the Opening Reception in West Ballroom D on the 1st Floor.
By registering early, you'll be able to collect your name badge, program, and handbag materials and avoid long lines on Monday morning.
17:30-19:30 Opening Reception
- West Ballroom D, 1
st Floor
You are invited to attend the opening reception of the 10th Annual BioPartnering North America. After checking in at Registration, please proceed to West Ballroom D on the 1st Floor for drinks and delicious hors d'œuvres.
Monday, 27 February
07:30-16:00 Registration
- Foyer, 1
st Floor
07:30-10:00 Continental Breakfast 
- Foyer, 1
st Floor
Title: Sponsored by: Farris, Vaughan, Wills and Murphy LLP
Join us for a refreshing continental breakfast of fresh orange juice, muffins and breakfast pastries. Freshly brewed coffee, decaffeinated coffee, breakfast and herbal teas will also be available.
09:00-09:15 Conference Welcome
- West Meeting Room 109-110, 1
st Floor
| On behalf of TVG, LSBC, our hosts and sponsors and supporters, welcome to the 10th Anniversary BioPartnering North America (BPN) in the beautiful city of Vancouver, BC. BPN is part of a global network that includes Canada, USA, Europe, China, India, Latin America and Australia. These regions are all centers of life science innovation and excellence. We offer heart-felt thanks to the Province of BC, which has actively supported BPN since its founding, and which continues to provide a world-class destination for the event. |

 |
BPN now attracts some of the world's most influential players in the biopharmaceutical world, and as you can see from this year's program, we will provide sessions found nowhere else. BPN has become one of a handful of partnering events for the biopharma industry, and certainly an event which is known for being a place where business gets done. As we say, "get a deal and ski." Whistler and other prime resorts are a short drive away.
Thank you for helping us keep BPN at the forefront of life science business partnering. If you like what you experience, join TVG as we provide partnering destinations around the world. Next stop, C21 BioVentures in California's Napa Valley, May 22-24, 2012. For the time being, enjoy all that BC has to offer.
We wish you a fruitful and enjoyable time.
Speaker:
Dr. Robert Lee Kilpatrick, Partner, TVG
09:15-09:45 Keynote Address - AstraZeneca
- West Meeting Room 109-110, 1
st Floor
09:45-10:15 Keynote Address - GlaxoSmithKline Inc
- West Meeting Room 109-110, 1
st Floor
Title: Advancing the Commercialization of Canadian Life Sciences
In this presentation the speaker will provide an overview of GSK Canada and highlight two key collaboration strategies (R&D/BD partnerships with GSK & the GSK Life Sciences Innovation Fund) to help advance innovation in the Life Sciences from conceptual to real medicines that positively impact patient outcomes.
Speaker:
Mr. Sav DiPasquale, Vice-President, Business Development and Corporate Planning, GlaxoSmithKline Canada
10:15-10:45 Keynote Address - Pfizer
- West Meeting Room 109-110, 1
st Floor
Title: Evolving Models of Innovation for Breakthrough Medicines: New Concepts at Pfizer

Speaker:
Dr. Uwe Schoenbeck, Chief Scientific Officer External Research and Development and Innovation, Pfizer
10:45-11:15 Keynote Address - Deloitte Recap
- West Meeting Room 109-110, 1
st Floor
Title: 2011 Life Sciences Deal Analysis Year-In-Review
Deloitte Recap’s Eric Walczykowski will provide a review of 2011’s transaction environment. Hear about the year’s key partnering deals, including M&As and equity financings and how these trends can provide insight into what to expect for 2012 and beyond.
Speaker:
Mr. Eric Walczykowski, Managing Director, Deloitte Recap, LLC
11:00-17:30 Face-to-Face Meetings - powered by biopartnering.com™
- West Ballroom A, 1
st Floor
| All meetings scheduled through biopartnering.com will be held at the numbered booths and lettered tables in West Ballroom A. Please visit the onsite Meeting & Message Desks for assistance. |
 |
| Sponsored by: |
 |
11:00-17:30 Exhibition: Spotlight on Biotechnology
- West Ballroom B, 1
st Floor
11:15-12:15 Leadership Session #1
- West Meeting Room 109-110, 1
st Floor
Title: Innovative Deal Making: From Negotiating the Right Terms to Building a Positive Long Term Relationship that Works
| Learn about innovation in deal making as we explore the partnership of Oncomed Pharmaceuticals and Bayer. This alliance was formed around the high unmet medical need for cancer treatments and the partner’s commitment to developing new and innovative treatments. Bayer was attracted to Oncomed’s anti-cancer stem cell platform. Oncomed benefited from significant additional funding, experienced late stage development skills from Bayer, and the promise of a strong financial future. Closing the deal was only the start of the relationship. Almost two years later this partnership is still going strong. Find out about the companies’ authentic experiences of working together every day, and learn what makes this collaboration work, from senior management to working team level and why. |
|
Chair:
Mr. Paul Hastings, President and Chief Executive Officer, OncoMed Pharmaceuticals, Inc.
Speaker:
Dr. Andreas Busch, Member of the Bayer HealthCare Executive Committee and Head of Research Pharmaceuticals and Animal Health, Bayer AG
Speaker:
Dr. Peter Nell, Director Business Development, Bayer HealthCare, LLC.
Speaker:
Mr. Sunil Patel, Senior Vice President, Corporate Development, OncoMed Pharmaceuticals, Inc.
11:15-12:15 Workshop #1 - Korea Life Science Sector Workshop
- West Meeting Room 103-104, 1
st Floor
Title: Recent Trends in an Emerging Market - Leading Companies in Korea
| Time |
Topic |
| 11:15 - 11:20 |
Chair will make an opening remark and present about trend of capital flow in emerging market - leading companies in Korea. Speaker: Mr. Steven Kim |
| 11:20 - 11:35 |
Corporate Overview of CrystalGenomics, Inc. Speaker: Mr. Steven Kim |
| 11:35 - 11:50 |
New Technology Platforms for BioBetter Development of Prime Pharm and Hanyang University Speaker: Dr. Yong Hoon Chung |
| 11:50 - 12:05 |
Nanoparticulate drug delivery solutions of Bio-Synectics Speaker: Mr. Jason Lee |
| 12:05 - 12:15 |
Closing Remarks and Question and Answer session. Speaker: Mr. Steven Kim |

Chair:
Mr. Steven Kim, Director, Business Development, CrystalGenomics, Inc.
Speaker:
Dr. Yong-Hoon Chung, Professor, Department of Microbiology and Immunology, Hanyang University College of Medicine, Seoul, Prime Pharm and Hanyang University
Speaker:
Mr. Jason Lee, Chief Executive Officer, Bio-Synectics, Inc.
12:30-13:30 Hot Buffet Lunch
- West Ballroom D, 1
st Floor
Refresh yourself with a delicious lunch buffet.
13:30-16:45 Podium Presentations - Stream 1
- West Meeting Room 101-102, 1
st Floor
13:30-16:45 Podium Presentations - Stream 2
- West Meeting Room 103-104, 1
st Floor
13:30-16:45 Podium Presentations - Stream 3
- West Meeting Room 105-106, 1
st Floor
13:45-17:15 Presenting Company Tabletop Meetings
- West Meeting Room 107-108, 1
st Floor
Companies will be available for informal face-to-face meetings for 30 minutes immediately following their presentation time.
16:45-17:45 Leadership Session #2
- West Meeting Room 109-110, 1
st Floor
Title: Strategies for Commercialization in Pacific Rim Markets through Deal Making
This session will initially focus on a single case study: how AstraZeneca is developing a commercial footprint in the Pacific Rim through the example of the first co-development deal ever done by Big Pharma in China. The recent licensing, co-development and commercialization deal with Chi-Med (part of Hutchison Medipharma), illustrates how Pacific Rim companies can accelerate global commercialization of their products by working with Big Pharma. Two other industry experts, will broaden the discussion beyond the AZ-Chi-Med case study to include trends driving dealmaking in Pacific Rim markets. All speakers have extensive experience in the region.
Chair:
Dr. Robert Lee Kilpatrick, Partner, TVG
Speaker:
Mr. Geoff Collett, Regional Business Development Director - Europe, AstraZeneca
Speaker:
Dr. Richard Soll, Senior Vice President of Integrated Services, WuXi AppTec
Speaker:
Dr. May Wang, Vice President, Clinical Research & Strategic Alliances, Hutchison Medi Pharma
17:45-18:45 Bus Transportation to Offsite Reception
- Front of the Vancouver Convention Centre Lobby
Coaches will transport delegates to the Vancouver Aquarium for the offsite networking reception.
The first coach will depart the front of the Vancouver Convention Centre Lobby at 17:45. Consequent coaches will depart every 15 minutes with the final coach departing at 18:45.
Last coach to return to the Vancouver Convention Centre vicinity at 20:00.
18:00-21:00 Offsite Networking Reception
- Vancouver Aquarium
Join us at the Vancouver Aquarium for a fantastic evening of stunning marine displays, wine and delicious hors d'oeuvres.
 |
 |
 |
 |
Tuesday, 28 February
07:30-16:00 Registration
- Foyer, 1
st Floor
07:30-10:00 Continental Breakfast
- Foyer, 1
st Floor
Join us for a refreshing continental breakfast of fresh orange juice, muffins and breakfast pastries. Freshly brewed coffee, decaffeinated coffee, breakfast and herbal teas will also be available.
09:00-10:00 Leadership Session #3
- West Meeting Room 109-110, 1
st Floor
Title: Matching Canadian Technology with Big Pharma’s need for Innovative New Drugs
Discover why Canada is the fourth largest biocluster in the world. Local British Columbia biotech CEOs, Ali Tehrani of Zymeworks and Simon Pimstone of Xenon will discuss their partnership with large pharmaceutical companies Merck and Genentech, represented by business development professionals Steven Xanthoudakis and Christian Hordo. Merck and Zymeworks recently came together through a mutual desire to develop new biologics with improved therapeutic properties. The end result! Merck has built on its portfolio of novel technologies and Zymeworks is closer to realizing the full value of its revolutionary bi-specific antibody platform. Genentech and Xenon recently announced the formation of a strategic alliance, worth up to $646M in milestones, to discover and develop compounds and companion diagnostics for the potential treatment of pain. The two companies share a common emphasis on using human genetics for drug development and this collaboration is structured to maximally leverage each organization's expertise. For biotechnology up and comers, don’t miss this opportunity to learn from successful Canadian deal makers.
Chair:
Mr. Don Enns, President, LifeSciences British Columbia
Speaker:
Mr. Christian Hordo, Manager, Business Development, Genentech, Inc.
Speaker:
Dr. Simon Pimstone, President & Chief Executive Officer, Xenon
Speaker:
Dr. Ali Tehrani, President and Chief Executive Officer, Zymeworks Inc.
Speaker:
Dr. Steven Xanthoudakis, Director, Licensing and External Research - Canada, Merck & Co Inc.
09:00-17:00 Face-to-Face Meetings - powered by biopartnering.com™
- West Ballroom A, 1
st Floor
| All meetings scheduled through biopartnering.com will be held at the numbered booths and lettered tables in West Ballroom A. Please visit the onsite Meeting & Message Desks for assistance. |
 |
| Sponsored by: |
 |
09:00-17:00 Exhibition: Spotlight on Biotechnology
- West Ballroom B, 1
st Floor
10:00-12:30 Podium Presentations - Stream 1
- West Meeting Room 101-102, 1
st Floor
10:00-12:30 Podium Presentations - Stream 2
- West Meeting Room 103-104, 1
st Floor
10:00-12:30 Podium Presentations - Stream 3
- West Meeting Room 105-106, 1
st Floor
10:15-13:00 Presenting Company Tabletop Meetings
- West Meeting Room 107-108, 1
st Floor
Companies will be available for informal face-to-face meetings for 30 minutes immediately following their presentation time.
12:30-13:30 Hot Buffet Lunch
- West Ballroom D, 1
st Floor
Refresh yourself with a delicious lunch buffet.
13:30-14:00 Workshop #2
- West Meeting Room 103-104, 1
st Floor
Title: Latin America –Recent market trends in the biotechnology & pharmaceutical industry
Life science executives in recent years have looked at the potential of emerging markets such as Latin America (LATAM). These markets offer a new venue for companies to launch products and develop innovations. The panel brings executives from established LATAM companies to offer an insight into the market potential of biotech and pharma products in those regions. The panelists will provide an overview of their companies and discuss:
- The potential benefits that LATAM market has to offer
- Business strategies needed to be successful in the fast growing LATAM market
- Partnering and collaboration opportunities
There would be a Q&A discussion open to Business Development & Partnering Executives who have interest in entering the LATAM market.
Chair:
Ms. Abhita Batra, Owner and Managing Director, Advanced Biopharma Consulting,LLC, Advanced Biopharma Consulting, LLC
Speaker:
Robert Russell, International Business Manager, Landsteiner Scientific SA, Mexico
Speaker:
Dr. Manuel Vilanova, Medical Director, Laboratorios Bioprofarma, Bago group membér , Argentina
13:30-16:00 Pharmaceutical Presentations
- West Meeting Room 109-110, 1
st Floor
In these presentations, the speakers will highlight the strengths of their company, which may include a company overview, an outline of products on the market, and information about alliances, existing or sought.
13:30-13:55 Pharmaceutical Presentation - Novartis
- West Meeting Room 109-110, 1
st Floor
Title: Partnering with Novartis

Novartis Compamy Presentation
Speaker: Mrs. Carolyne Zimmermann, Global Head, Search, Evaluations and Negotiations, Novartis Pharma AG
14:00-14:25 Pharmaceutical Presentation - Actelion Pharmaceuticals Ltd
- West Meeting Room 109-110, 1
st Floor
Title: Partnering with Actelion Pharmaceuticals Ltd

Actelion Pharmaceuticals Ltd Company Presentation
Speaker: Mr. Nicholas Franco, Executive Vice President, Chief Business Development Officer, Actelion Pharmaceuticals Ltd
14:30-14:55 Pharmaceutical Presentation - Merck
- West Meeting Room 109-110, 1
st Floor
Title: Partnering with Merck

Merck Company Presentation
Speaker: Dr. Steven Bartz, Director, Licensing & External Research, Merck
14:45-15:45 Workshop #3
- West Meeting Room 103-104, 1
st Floor
Title: Need + Innovation = Opportunity: Alberta, Canada
Have a few refreshments, network and hear about the exciting opportunities in Alberta!
This workshop will profile activities within Alberta’s world class health and biotechnology institutes as well as showcase companies that are active in the region. Join us to explore Alberta’s opportunities.
Chair:
Mr. Ryan Radke, President, BioAlberta
Speaker:
Dr. Robert Foster, Chief Executive Officer, Isotechnika Pharma Inc.
Speaker:
Dr. Svetlana Sapelnikova, Marketing and Business Development Manager, KMT Hepatech Inc.
Speaker:
Dr. Yun Tam, Co-founder, President and Chief Scientific Officer, SinoVeda Canada Inc.
15:00-15:25 Pharmaceutical Presentation - Genentech
- West Meeting Room 109-110, 1
st Floor
Title: Partnering with Genentech
Considered the founder of the biotechnology industry, Genentech has been delivering on the promise of biotechnology for more than 35 years. Following the merger of Genentech and Roche in 2009, Genentech Research and Early Development (gRED) operates as an independent center within the Roche Group. gPartnering supports gRED with innovation through collaboration. We welcome collaboration opportunities at any development stage between discovery and clinical proof-of-concept (typically phase II) in oncology, immunology, neuroscience, ophthalmology, and microbial pathogenesis. We further seek to identify novel platform technologies for antibodies and small molecules, and technologies for biomarker identification
Speaker: Mr. Christian Hordo, Manager, Business Development, Genentech, Inc.
15:30-15:55 Pharmaceutical Presentation
- West Meeting Room 109-110, 1
st Floor
Pharmaceutical Company Presentation
15:45-16:00 University of Calgary Master of Biomedical Technology (MBT)
- West Meeting Room 103-104, 1
st Floor
Title: We Are The MBT
16:00-16:15 BIOTECanada & TVG | Student Bursary Awards Ceremony
- West Meeting Room 103-104, 1
st Floor
| TVG is strongly committed to the Canadian biotechnology industry and the next generation of life science industry leaders. We invest in the future of a vibrant biotech industry of Canada. Recipients of the BIOTECanada Student Bursary scholarships will be announced. |
 |
| |
 |
16:00-17:30 Closing Session
- West Meeting Room 109-110, 1
st Floor
Title: The Rise of the Corporate VC: Not a Contradiction in Terms?
It's a tough time to raise capital; for many young biotech companies there are few financing options. The venture world has changed all out of recognition in recent years, with many venture capitalists being forced from the life sciences space, or focused solely on late stage deals. Public markets are closed to all but the very best life sciences companies.
Against this backdrop, we are seeing the rise of corporate venture capital funding, with many Big Pharma companies--but not all--operating their own captive venture funds, investing along with, and like, "traditional" venture funds.
What is the mission of these corporate venture operations? Are they acting as true VC's, seeking a purely financial return, or are some acting like stalking horses, just seeing what's out there in terms of innovation, product development and company or product acquisition candidates--or "all of the above"? What different corporate VC models are we seeing, and which ones are successful--and what does "success" mean for a corporate VC?
This expert and experienced panel will explore these and other intriguing and important questions in a lively and candid discussion.
Chair:
Mr. Bruce W. Jenett, Partner, Co-Chair, Global Life Sciences Sector, DLA Piper LLP (US)
Speaker:
Dr. Steve Kuemmerle, Head, Biotech Venture Investments , Abbott Biotech Ventures, Inc.
Speaker:
Dr. Henry Skinner, Head Strategic Alliances, Therapeutics , Novartis International AG
Speaker:
Dr. Sam Wu, Managing Director, MedImmune Ventures, Inc.
17:30-18:30 Farewell Drinks Reception
- Foyer, 1
st Floor
Title: Sponsored by: The Student Biotechnology Network
An opportunity to say goodbye to fellow delegates and begin planning for the 11th Annual BioPartnering North America.